_Market_1.jpg)
Global Site Management Organizations (SMO) Market is expected to grow at an 8.5% CAGR during the forecast period for 2025-2034.
Site management organizations (SMO) are essential elements of biopharmaceutical companies. Such organizations help to solve the issues related to clinical trials. SMO offers various services such as preparing submissions to institutional review boards (IRBs), patient enrollment, hiring study staff, addressing site-specific study activities, and managing clinical research site operations.
The driving factors of the site management organizations market include increasing demand for drug discoveries, high prevalence of chronic diseases, a growing number of clinical trials for novel drugs & therapies, surging pharmaceutical industries, and rising preference for clinical trial outsourcing to the CROs (contract research organizations). With the growing drug development processes, the number of clinical trials and complexities in the clinical trial phases also increases, boosting the demand for SMOs in the coming years. However, intense competition among the market players is a big challenge to this market.
The site management organizations market is segmented into Therapeutic Areas, Trial Phases, Clinical Trial Components, Interventions Types, And Regions. The market is classified into oncology, central nervous system (CNS), cardiovascular, and infectious diseases in terms of therapeutic areas. The oncology segment would be the fastest-growing segment of this market in the upcoming years, owing to the increasing cancer cases and the growing elderly population. The trial phases segment is grouped into four phases: phase I, phase II, phase III, and IV. Based on clinical trial components, the market is divided into site management, onsite monitoring, project management, and other clinical trial components. The site management segment dominated this market in 2020 due to the increasing trend of clinical trial outsourcing. By interventions types, the market comprises therapeutics, devices, and surgical procedures. Regionally, the market is analysed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America region is expected to account for the highest share of this market over the forecast years, followed by Europe, which is attributed to the rising investments in drug development and well-established healthcare systems & biopharma companies in this region.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 8.5% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Therapeutic Areas, By Trial Phases, By Clinical Trial Components, By Interventions Types |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
CROMSOURCE (Italy), CMIC Group (Canada), FOMAT Medical Research (U.S.), George Clinical (Australia), Fidelis Research (Bulgaria), Parexel (U.S.), Pharm-Olam (U.S.), Scandinavian CRO (Sweden), Veristat (U.S.), TFS HealthScience (Sweden), Trialbee (Sweden), Tigermed (China), Veeda Clinical Research (Ahmedabad), WCCT Global (U.S.), Worldwide Clinical Trials (U.S.), Novotech, ERG Holding, Elligo Health Research, Apex Medical Research, ClinChoice Private Limited, FOMAT Medical Research, EPSI, AusTrials, Altasciences Company, Beijing Aisimo Medical Science and Technology Co., Ltd, MEDEX, Ethic Co.Ltd, ACTG-CRO, CIDAL OneOncology, MPR Development Group, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Site Management Organizations Market Snapshot
Chapter 4. Global Site Management Organizations Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Therapeutic Area, Estimates & Trend Analysis
5.1. By Therapeutic Areas, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Areas:
5.2.1. Oncology
5.2.2. CNS
5.2.3. Cardiovascular
5.2.4. Infectious Diseases
5.2.5. Other Therapeutic Area
Chapter 6. Market Segmentation 2: By Tiral Phases Estimates & Trend Analysis
6.1. By Trial Phases & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Trial Phases:
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
Chapter 7. Market Segmentation 3: By Clinical Trial Components Estimates & Trend Analysis
7.1. By Clinical Trial Components & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Clinical Trial Components:
7.2.1. Site Management
7.2.2. Onsite Monitoring
7.2.3. Project Management
7.2.4. Other Clinical Trial Components
Chapter 8. Market Segmentation 4: By Interventions Types Estimates & Trend Analysis
8.1. By Interventions Types & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Interventions Types
8.2.1. Therapeutics
8.2.2. Devices
8.2.3. Surgical Procedure
Chapter 9. Site Management Organizations Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Site Management Organizations Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas, 2021-2034
9.1.2. North America Site Management Organizations Market revenue (US$ Million) estimates and forecasts By Trial Phases, 2021-2034
9.1.3. North America Site Management Organizations Market revenue (US$ Million) estimates and forecasts By Clinical Trial Components, 2021-2034
9.1.4. North America Site Management Organizations Market revenue (US$ Million) estimates and forecasts by Interventions Types, 2021-2034
9.1.5. North America Site Management Organizations Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Site Management Organizations Market revenue (US$ Million) By Therapeutic Areas, 2021-2034
9.2.2. Europe Site Management Organizations Market revenue (US$ Million) By Trial Phases, 2021-2034
9.2.3. Europe Site Management Organizations Market revenue (US$ Million) By Clinical Trial Components, 2021-2034
9.2.4. Europe Site Management Organizations Market revenue (US$ Million) estimates and forecasts by Interventions Types, 2021-2034
9.2.5. Europe Site Management Organizations Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Site Management Organizations Market revenue (US$ Million) By Therapeutic Areas, 2021-2034
9.3.2. Asia Pacific Site Management Organizations Market revenue (US$ Million) By Trial Phases, 2021-2034
9.3.3. Asia Pacific Site Management Organizations Market revenue (US$ Million) By Clinical Trial Components, 2021-2034
9.3.4. Asia Pacific Site Management Organizations Market revenue (US$ Million) estimates and forecasts by Interventions Types, 2021-2034
9.3.5. Asia Pacific Site Management Organizations Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Site Management Organizations Market revenue (US$ Million) By Therapeutic Areas, (US$ Million) 2021-2034
9.4.2. Latin America Site Management Organizations Market revenue (US$ Million) By Trial Phases, (US$ Million) 2021-2034
9.4.3. Latin America Site Management Organizations Market revenue (US$ Million) By Clinical Trial Components, (US$ Million) 2021-2034
9.4.4. Latin America Site Management Organizations Market revenue (US$ Million) estimates and forecasts by Interventions Types, 2021-2034
9.4.5. Latin America Site Management Organizations Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Site Management Organizations Market revenue (US$ Million) By Therapeutic Areas, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Site Management Organizations Market revenue (US$ Million) By Trial Phases, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Site Management Organizations Market revenue (US$ Million) By Clinical Trial Components, (US$ Million) 2021-2034
9.5.4. Middle East & Africa Site Management Organizations Market revenue (US$ Million) estimates and forecasts by Interventions Types, 2021-2034
9.5.5. Middle East & Africa Site Management Organizations Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. CROMSOURCE
10.2.2. CMIC
10.2.3. FOMAT Medical Research
10.2.4. George Clinical
10.2.5. Fidelis Research
10.2.6. Parexel
10.2.7. Pharm-Olam
10.2.8. Plexus Research
10.2.9. Scandinavian CRO
10.2.10. Veristat
10.2.11. Syneos Health
10.2.12. TFS HealthScience
10.2.13. Trialbee
10.2.14. Tigermed
10.2.15. Veeda Clinical Research
10.2.16. Velocity Clinical Research
10.2.17. Synexus Limited
10.2.18. Accelerated Enrollment Solutions (AES)
10.2.19. WCCT Global
10.2.20. Worldwide Clinical Trials
10.2.21. Novotech
10.2.22. ERG Holding
10.2.23. Elligo Health Research
10.2.24. Apex Medical Research
10.2.25. ClinChoice Private Limited
10.2.26. FOMAT Medical Research
10.2.27. EPSI
10.2.28. AusTrials
10.2.29. Altasciences Company
10.2.30. Beijing Aisimo Medical Science and Technology Co., Ltd
10.2.31. MEDEX
10.2.32. Ethic Co.Ltd
10.2.33. ACTG-CRO
10.2.34. CIDAL
10.2.35. OneOncology
10.2.36. MPR Development Group
10.2.37. Other Prominent Players
Global Site Management Organizations Market, by Therapeutic Areas, 2020-2030 (Value US$ Mn)
Global Site Management Organizations Market, by Trial Phases, 2020-2030 (Value US$ Mn)
Global Site Management Organizations Market, by Clinical Trial Components, 2020-2030 (Value US$ Mn)
Global Site Management Organizations Market, by Interventions Types, 2020-2030 (Value US$ Mn)
Global Site Management Organizations Market, by Region, 2020-2030 (Value US$ Mn)
North America Site Management Organizations Market, by Country, 2020-2030 (Value US$ Mn)
Europe Site Management Organizations Market, by Country, 2020-2030 (Value US$ Mn)
Asia Pacific Site Management Organizations Market, by Country, 2020-2030 (Value US$ Mn)
Latin America Site Management Organizations Market, by Country, 2020-2030 (Value US$ Mn)
Middle East & Africa Site Management Organizations Market, by Country, 2020-2030 (Value US$ Mn)
Competitive Landscape
Latest Strategic Developments
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
